Nanjing, China, September 2025 — WixBio’s Overseas Business and Technical Departments recently hosted a face-to-face technical exchange meeting in Nanjing with representatives from UNIVET, a partner company from Kazakhstan. The discussions focused on critical technical aspects, including testing methodologies for poultry vaccines, epidemiological compatibility of vaccine strain subtypes, and adaptability to regional conditions.
The meeting aimed to optimize the performance of WixBio’s vaccine products in the Central Asian market, ensuring consistent and effective immune protection across diverse climatic and farming environments. WixBio’s technical team provided a detailed overview of the company’s processes and quality control standards for vaccine antigen preparation, potency testing, specific pathogen-free (SPF) chicken embryo virus titration, and hemagglutination inhibition (HI) antibody monitoring. Additionally, they outlined the company’s approach to strain selection and updates based on country-specific epidemiological data.
Given the recent prevalence of avian influenza (H9N2), Newcastle disease (G-7 strain), and infectious bronchitis in Kazakhstan, both parties thoroughly evaluated the compatibility of existing vaccine combinations. They also reached a preliminary agreement on the future development of customized multivalent vaccines. WixBio highlighted its robust customization capabilities, enabling rapid adjustments to vaccine formulations to deliver tailored disease prevention strategies, aligning with a “one country, one strategy; one region, one solution” approach.
UNIVET representatives commended WixBio’s technical expertise and responsiveness, stating, “This in-depth exchange has strengthened our confidence in a long-term partnership with WixBio. Their products have demonstrated outstanding immunogenicity and stability in Kazakhstan, earning widespread approval from local farmers and regulatory authorities.”
This Nanjing meeting not only reinforced technical collaboration but also established a strong foundation for expanding WixBio’s presence in Central Asia. Leveraging its advanced research and development capabilities and global service infrastructure, WixBio remains committed to delivering comprehensive animal health solutions to clients worldwide, encompassing product customization, technical support, and after-sales services.
